+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 0Years - 45Years
All Genders
ID03911128

A Pilot Study Protocol for a Personalized Treatment Platform in Infants, Children, and Young Adults 0-45 Years with Newly Diagnosed Acute Lymphoblastic Leukaemia

Led by Mats Heyman · Updated on 2026-08-13

500

Participants Needed

57

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating a comprehensive treatment approach for infants, children, and young adults aged 0 to 45 years with newly diagnosed acute lymphoblastic leukaemia ALL. This pilot study gathers experiences from multiple renowned study groups to establish a unified platform protocol that supports personalized risk-based diagnosis and treatment. The study aims to optimize survival and quality of life, addressing both under-treatment and over-treatment risks in this patient group. The study is observational and does not involve specific experimental interventions but uses standard of care treatments defined by the master protocol. It incorporates a personalized algorithm based on clinical and genetic factors to guide treatment decisions. High-risk patients may be considered for advanced therapies such as Chimeric Antigen Receptor T-cell CAR-T therapy as alternatives to more intensive treatments. The study also supports translational and therapy-related research within this platform. Participants are observed under routine care at participating pediatric oncology or adult hematology centers. Data collection includes diagnosis confirmation, treatment response, and survival outcomes over a 5-year period. Researchers monitor event-free survival and overall survival compared to historical controls, aiming to improve long-term results. The study runs until June 2033, with ongoing data registration, collaboration optimization, and quality checks to support future randomized trials.

CONDITIONS

Brief Title

A Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia

Research Team

T

Trial Central Office

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here